Transactivation system for mammalian cells
View Patent ↗The present invention is directed generally to compositions and methods for expressing recombinant proteins in a mammalian host cell using a co-expressed transcriptional activator. In particular, the invention provides vectors, host cells, and methods of expressing at least one desired polypeptide by transfecting a mammalian host cell with cistrons encoding a transactivator, a desired polypeptide, and an apoptosis-protective protein.
1. A method of expressing a desired antibody in a mammalian host cell comprising the steps of:
growing the mammalian host cell containing a nucleic acid, said nucleic acid comprising:
a first cistron encoding a first desired antibody polypeptide under the control of a first promoter;
a second cistron encoding a second desired antibody polypeptide under the control of the first promoter;
a third cistron encoding a CREB protein under control of a second promoter,
a fourth cistron encoding an apoptosis-protective protein under control of the second promoter or optionally under control of a third promoter, wherein said second promoter or said third promoter that controls said fourth cistron comprises a CREB-binding element;
wherein the first and second cistrons are on a retroviral vector and are separated by an internal ribosome entry site (IRES), the third cistron is on the same retroviral vector or optionally on a different vector, and the fourth cistron is on the same retroviral vector or optionally on a different vector;
expressing the CREB protein at a level that can cause host cell death in the absence of the apoptosis-protective protein;
expressing the apoptosis-protective protein at a level to inhibit death of the host cell from the CREB protein; and
expressing the antibody polypeptide in the mammalian host cell, wherein the production rate of the desired antibody is enhanced at least five-fold by the combination of the CREB protein and the apoptosis-protective protein.
2. A mammalian host cell comprising:
a retroviral vector, comprising a cistron encoding an antibody polypeptide under control of a first promoter and a ubiquitous chromatin opening element (UCOE) operably linked to the cistron; and
a cistron encoding a CREB protein under control of a second promoter, wherein the CREB protein is present in the host cell in amounts that could cause cell death of the host cell without an apoptosis protective protein;
a cistron encoding the apoptosis-protective protein under control of a third promoter, wherein the apoptosis-protective protein is present in the host cell in amounts sufficient to inhibit death of the host cell from the transactivator and wherein said third promoter comprises a CREB-binding element; and
wherein the production rate of the desired antibody in the host cell is enhanced at least five-fold by the combination of the CREB protein and the apoptosis protective protein.